Madrigal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: -26.71

Madrigal Pharmaceuticals, Inc. Interest Coverage Ratio is -26.71 for the Trailing 12 Months (TTM) ending March 31, 2025, a -11.71% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Madrigal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was -30.26, a -38.20% change year over year.
  • Madrigal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -48.96, a -91.43% change year over year.
  • Madrigal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -571.46, a 1,016.12% change year over year.
  • Madrigal Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was -51.20, a -1.31% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)